<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="activation and apoptosis from inflammatory cytokines, especially tumor necrosis factor" exact="alpha" post="(TNFÎ±) [34]. According to recent unpublished data from autopsies,"/>
 <result pre="protective immunity and inflammation is crucial to overcome the infection." exact="Prompt" post="recruitment and expansion of virus-specific lymphocytes can lead to"/>
 <result pre="membrane-fusion inhibitor active against influenza [148]. More trials are underway." exact="Ribavirin" post="has been empirically included into various treatment protocols for"/>
 <result pre="even though there is little evidence for its efficacy [149]." exact="Ribavirin" post="is a nucleoside analogue that inhibits viral RNA-dependent RNA"/>
 <result pre="with in vitro activity against SARS-CoV only at high concentrations." exact="Ribavirin" post="has been used for the treatment of SARS and"/>
 <result pre="MERS, mostly in combination with IFNs. Of 30 trials evaluating" exact="ribavirin" post="in patients with SARS, 26 were classified as inconclusive"/>
 <result pre="a high proportion of treated patients [150]. With these premises" exact="ribavirin" post="likely has limited value for the treatment of Covid-19."/>
 <result pre="likely has limited value for the treatment of Covid-19. 6.2." exact="Chloroquine" post="and Hydroxychloroquine Chloroquine and hydroxychloroquine inhibit in vitro SARS-CoV-2"/>
 <result pre="limited value for the treatment of Covid-19. 6.2. Chloroquine and" exact="Hydroxychloroquine" post="Chloroquine and hydroxychloroquine inhibit in vitro SARS-CoV-2 [151]. These"/>
 <result pre="value for the treatment of Covid-19. 6.2. Chloroquine and Hydroxychloroquine" exact="Chloroquine" post="and hydroxychloroquine inhibit in vitro SARS-CoV-2 [151]. These agents"/>
 <result pre="the treatment of Covid-19. 6.2. Chloroquine and Hydroxychloroquine Chloroquine and" exact="hydroxychloroquine" post="inhibit in vitro SARS-CoV-2 [151]. These agents appear to"/>
 <result pre="alternatives, the use of hydroxychloroquine, alone or in combination with" exact="azithromycin" post="(an antibiotic added mainly for its anti-inflammatory effects possibly"/>
 <result pre="clinical outcome. At day 6, 70% of patients who received" exact="hydroxychloroquine" post="(n = 20) achieved viral clearance compared to 12.5%"/>
 <result pre="out the potential synergistic effect of the concomitant use of" exact="azithromycin" post="since all the patients receiving the combination achieved viral"/>
 <result pre="were observed including the fact that six patients in the" exact="hydroxychloroquine" post="group that met the inclusion criteria were removed from"/>
 <result pre="still unpublished small clinical trial randomized 62 patients to receive" exact="hydroxychloroquine" post="or placebo and found a reduction of time to"/>
 <result pre="and the need for mechanical ventilation based on exposure to" exact="hydroxychloroquine" post="alone or with azithromycin, placing a cautionary note. In"/>
 <result pre="an increased overall mortality was identified in patients treated with" exact="hydroxychloroquine" post="alone [155]. Similarly, in a retrospective analysis of hospitalized"/>
 <result pre="probability of treatment weighting approach, did not find evidence of" exact="hydroxychloroquine" post="efficacy [156]. On 21 April, the National Institute of"/>
 <result pre="against the use, outside clinical trials, of the combination of" exact="hydroxychloroquine" post="plus azithromycin, because of the potential for toxicities. Also,"/>
 <result pre="Also, it was recommended to pay attention toward patients receiving" exact="chloroquine" post="or hydroxychloroquine for adverse effects, especially prolonged QTc interval."/>
 <result pre="was recommended to pay attention toward patients receiving chloroquine or" exact="hydroxychloroquine" post="for adverse effects, especially prolonged QTc interval. 6.3. SARS-CoV2-Specific"/>
 <result pre="SARS and MERS on the combined use of IFN and" exact="ribavirin" post="failed to show any improvement in mortality or viral"/>
 <result pre="recent COVID-19 series found that patients with ARDS treated with" exact="methylprednisolone" post="exhibited lower mortality (46% vs. 62%, hazard ratio for"/>
 <result pre="Adults Hospitalized with Severe Covid-19N. Engl. J. Med.20203821787179910.1056/NEJMoa200128232187464 144.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="in inhibiting SARS-CoV-2 infection in vitroCell Discov.2020610.1038/s41421-020-0156-0 152.GautretP.LagierJ.C.ParolaP.HoangV.T.MeddebL.MailheM.DoudierB.CourjonJ.GiordanengoV.VieiraV.E.et al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: Results of an open-label"/>
 <result pre="Dissemination of Results and Its Consequences Regarding the Use of" exact="Hydroxychloroquine" post="for COVID-19Ann. Intern. Med.202010.7326/M20-122332227189 154.ChenZ.HuJ.ZhangZ.Shan JiangS.HanS.YanD.ZhuangR.HuB.ZhangZ.Efficacy of hydroxychloroquine in"/>
 <result pre="Use of Hydroxychloroquine for COVID-19Ann. Intern. Med.202010.7326/M20-122332227189 154.ChenZ.HuJ.ZhangZ.Shan JiangS.HanS.YanD.ZhuangR.HuB.ZhangZ.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: Results of a randomized clinical"/>
 <result pre="with COVID-19: Results of a randomized clinical trialmedRxiv202010.1101/2020.03.22.20040758 155.MagagnoliJ.NarendranS.PereiraF.CummingsT.HardinJ.W.SuttonS.S.AmbatiJ.Outcomes of" exact="hydroxychloroquine" post="usage in United States veterans hospitalized with Covid-19medRxiv202010.1101/2020.04.16.20065920 156.MahevasM.TranV.-T.RoumierM.ChabrolA.PauleR.GuillaudC.GallienS.LepeuleR.SzwebelT.-A.LescureX.et"/>
 <result pre="hospitalized with Covid-19medRxiv202010.1101/2020.04.16.20065920 156.MahevasM.TranV.-T.RoumierM.ChabrolA.PauleR.GuillaudC.GallienS.LepeuleR.SzwebelT.-A.LescureX.et al.No evidence of clinical efficacy of" exact="hydroxychloroquine" post="in patients hospitalized for COVID-19 infection with oxygen requirement:"/>
</results>
